Tarle, Alfred .
HRN: 13-71-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2024
CEFTRIAXONE 1G (VIAL)
12/26/2024
01/02/2025
IV
1g
Q12
TBI; Lacerated Wound; Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft TissueCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes